Lily Cheung - Jan 23, 2024 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role: Chief Human Resource Officer
Signature: /s/Mike Ouimette, attorney-in-fact
Stock symbol: PLRX
Transactions as of: Jan 23, 2024
Transactions value $: $0
Form type: 4
Date filed: 1/24/2024, 04:57 PM
Previous filing: Jan 23, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PLRX	Common Stock	Award	$0	+26K	+3270.44%	$0.00	26.8K	Jan 23, 2024	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PLRX	Stock Option (Right to Buy)	Award	$0	+52K		$0.00	52K	Jan 23, 2024	Common Stock	52K	$17.44	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These are restricted stock units that vest in three substantially equal annual installments beginning January 16, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date.
F2	Includes 795 shares of Common Stock acquired by the Reporting Person pursuant to an Employee Stock Purchase Plan program.
F3	1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date.